Expert Review of Anti-Infective Therapy

Papers
(The TQCC of Expert Review of Anti-Infective Therapy is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies182
Antimicrobial resistance in low- and middle-income countries: current status and future directions118
Calycosin: a Review of its Pharmacological Effects and Application Prospects74
Current and emerging strategies to combat antimalarial resistance64
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae55
CAR-T cell therapy and infection: a review53
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis51
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management50
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials49
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal44
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications42
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities39
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies37
Bacterial death from treatment with fluoroquinolones and other lethal stressors37
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-235
Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs33
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications33
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations33
Bacteria and fungi as major bio-sources to fabricate silver nanoparticles with antibacterial activities31
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy31
A review on favipiravir: the properties, function, and usefulness to treat COVID-1930
Dengue vaccine: an update30
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies28
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study28
Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan27
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis27
Therapeutic strategies to address monkeypox27
Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints26
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV26
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria26
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams25
Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases24
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs23
The war against bacteria, from the past to present and beyond23
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol22
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections22
Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress21
Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis20
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance20
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects20
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition20
Impact of bacterial infections on erythropoiesis20
Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review19
Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention18
Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease18
Implementation of antimicrobial stewardship to reduce antimicrobial drug resistance18
Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis18
A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications18
Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads18
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?17
Fostemsavir for the treatment of HIV17
Anti-inflammatory effects of GLP-1 in patients with COVID-1917
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis17
Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: A placebo controlled randomized trial16
Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies16
Bacteriophages for ESKAPE: role in pathogenicity and measures of control15
The rise of mucormycosis in Covid-19 patients in India15
Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions15
Predictors of mortality in invasive pneumococcal disease: a meta-analysis15
Diagnosis, prevention, and treatment of coronavirus disease: a review15
Drug repurposing: new strategies for addressing COVID-19 outbreak15
Managing sepsis in the era of precision medicine: challenges and opportunities14
Recent innovations and new applications of outpatient parenteral antimicrobial therapy14
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice14
Molecular diagnosis of toxoplasmosis: recent advances and a look to the future14
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy14
Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment14
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world14
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review13
COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention13
An update on endotoxin neutralization strategies in Gram-negative bacterial infections12
Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori12
Reemergence of monkeypox: prevention and management12
Spontaneous loss of chronic HBV infection markers in treatment-naïve children: a systematic review and pooled meta-analyses12
Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey12
Clinical impact of procalcitonin-based algorithms for duration of antibiotic treatment in critically ill adult patients with sepsis: a meta-analysis of randomized clinical trials12
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria12
The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review11
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives11
Lifestyle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs11
Lactic acid bacteria: prominent player in the fight against human pathogens11
Potential effectiveness and adverse implications of repurposing doxycycline in COVID-19 treatment11
Bacterial resistance to antibiotics: access, excess, and awareness in Bangladesh11
Self-medication Behavior with antibiotics: a national cross-sectional survey in Sri Lanka11
Impact of HIV infection on aging and immune status11
Scrub typhus and antibiotic-resistant Orientia tsutsugamushi11
Exacerbation of antimicrobial resistance: another casualty of the COVID-19 pandemic?11
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision11
Application of platelet-rich plasma in traumatic bone infections11
Sepsis in the critically ill patient: current and emerging management strategies11
Practical diagnostic algorithms for Chagas disease: a focus on low resource settings11
The antifungal pipeline for invasive fungal diseases: what does the future hold?11
Lack of antibiotic knowledge and misuse of antibiotics by medical students in Mali: a cross-sectional study10
Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries10
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan10
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)10
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-1910
Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box10
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas 10
Current updates in diagnosis of male urogenital tuberculosis10
Classification for β-lactamases: historical perspectives10
The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies10
Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring10
Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial10
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases9
Antibiotic use among hospitalized children with lower respiratory tract infections: a multicenter, retrospective study from Punjab, Pakistan9
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review9
Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures9
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae9
The antifungal activity of caspofungin in combination with antifungals or non-antifungals against Candida species in vitro and in clinical therapy9
Clostridioides difficile infection: an emerging zoonosis?9
Carbapenem-resistant Klebsiella pneumoniae : the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge9
Invasive Candida infection: epidemiology, clinical and therapeutic aspects of an evolving disease and the role of rezafungin9
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development9
Escalation of antimicrobial resistance among MRSA part 1: focus on global spread9
Outpatient treatment options to address the SARS-CoV-2 variant Omicron9
Visceral leishmaniasis elimination in India: progress and the road ahead9
0.047608852386475